Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation


Phase N/A Results

Summary of Purpose

The key focus of this survey will be to collect data on physicians awareness of the content of the Pradaxa® Prescriber Guide and the extent to which risk awareness is communicated to patients. The data collected with atrial fibrillation patients will show if and how well this information is received and understood.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 July 2016.

1 Jan 2015 25 Mar 2015 1 Aug 2015 1 Aug 2015 1 Jul 2016 28 Jul 2016
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



Trial Design

  • Observation: Cohort
  • Perspective: Cross-Sectional
  • Sampling: Probability Sample